One of the goals of our study was to explore the relationship between MYCN amplification and RB1 inactivation to determine if a subset of retinoblastomas can be driven by a single oncogenic lesion (MYCN amplification) without RB1 loss [1]. This evidence concerns the gene RB1 and retinoblastoma.